Researchers from Korea and the US have developed an oral nanomedicine that uses gut bacterial metabolites to enhance T cell stemness for cancer treatment.
Researchers have identified how the thymus-derived hormone thymulin can suppress age-related inflammation and potentially enhance cancer immunotherapy.